ADMA Biologics Inc

Healthcare · Biotechnology

9.40$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

ADMA Biologics Inc (ADMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 684 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADMA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	27	24	18	85	73	108	91	118	106	89	78	143	138	127	211	192	190	208	236	233	239	276	308	297	301	348	341	343	349	329	351	376	391	489	511	558	569	624	665	684
Current Assets	25	22	16	44	31	63	46	74	63	45	38	104	97	86	165	143	140	154	177	171	175	209	240	223	224	270	264	266	274	257	276	304	318	331	352	400	403	467	511	528
Cash	7.9	9.9	8.5	26	14	43	26	55	42	23	17	74	48	27	101	76	60	56	62	42	34	51	70	52	35	87	69	63	74	51	45	88	87	103	72	90	61	88	138	136
Cash & Short-Term Investments	19	15	8.8	26	14	43	26	55	42	23	17	74	48	27	101	76	60	56	62	42	34	51	70	52	35	87	69	63	74	51	45	88	87	103	72	90	61	88	138	136
Receivables	1.3	1.0	0.8	2.3	1.5	3.9	3.7	3.8	4.1	1.4	1.3	5.1	7.3	3.5	7.1	6.5	6.3	13	15	24	20	29	26	19	21	16	27	37	31	27	50	30	50	50	99	110	138	158	136	138
Inventory	4.6	5.0	5.3	13	13	13	12	12	14	19	18	24	40	53	52	56	70	82	94	100	114	125	139	146	163	163	164	162	163	173	178	180	172	170	172	191	197	206	222	239
Property, Plant & Equipment	2.1	2.0	1.9	29	30	30	31	30	30	30	30	29	31	32	35	37	40	45,852	44	53	48	51	53	55	57	58	57	56	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5
Intangible Assets	0.0	0.0	0.0	6.0	5.7	4.8	4.6	4.4	4.2	4.0	3.8	3.6	3.4	3.2	3.0	2.8	2.6	2.4	2.3	2.1	1.9	1.7	1.5	1.4	1.2	1.0	0.8	0.7	0.5	0.5	0.3	0.5	0.5	0.5	0.5	0.5	0.5	0.6	0.6	0.6
Total Liabilities	28	28	28	57	60	68	68	66	69	69	68	96	102	101	114	115	119	119	123	121	136	135	181	183	200	196	195	196	198	194	197	188	159	140	137	160	138	147	275	276
Current Liabilities	9.2	11	13	16	13	9.4	9.4	6.9	9.9	9.6	8.3	10	15	14	14	13	16	20	21	18	32	30	32	28	44	39	37	42	42	50	53	44	45	56	53	75	56	70	74	76
Short-Term Debt	4.5	6.1	6.7	6.7	3.9	3.3	40	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.3	0.4	0.5	0.6	0.7	0.6	0.7	0.9	1.0	1.0	1.0	1.0	1.1	1.1	1.2	1.2	1.2	1.1	3.6	3.9	4.5	4.9
Accounts Payable	2.8	2.6	3.9	4.7	9.2	5.9	5.7	3.1	5.3	5.9	5.5	6.8	9.0	9.2	9.2	6.9	8.0	11	12	6.2	17	12	14	11	25	13	13	12	11	16	17	14	16	20	21	30	24	23	21	32
Long-Term Debt	14	12	11	11	16	28	28	29	29	29	41	82	83	68	96	97	97	93	93	94	94	95	138	140	141	143	144	140	142	131	131	131	101	72	73	73	70	69	194	193
Shareholders' Equity	-0.2	-4.5	-11	28	13	40	23	52	37	20	10	47	36	26	96	77	71	88	113	112	103	141	127	114	100	152	146	147	151	135	154	188	232	349	373	398	431	477	390	408
Retained Earnings	-102	-107	-113	-123	-138	-151	-169	-183	-198	-216	-230	-243	-254	-265	-284	-304	-321	-340	-359	-378	-395	-412	-437	-451	-466	-478	-485	-491	-489	-506	-488	-456	-420	-309	-282	-247	-211	-162	-116	-79
Shares Outstanding	13	13	13	16	26	45	45	43	46	46	46	52	59	59	74	86	88	97	116	127	134	181	196	196	196	203	222	223	234	226	236	242	245	246	245	249	245	244	240	230

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings